New study: The Impact of Plasma Derived Therapies in Europe

New study: The Impact of Plasma Derived Therapies in Europe

June 21, 2021

We are pleased to announce the publication of a new report highlighting the barriers impeding collection of human plasma in Europe.

Commissioned by Takeda, the report focuses on the health and economic case for ensuring a sustainable supply of plasma in Europe, detailing the current situation and examining the future for patients suffering from rare diseases that require plasma derived therapies.

Learn more about the study

For further information, please contact Partner Christian Jervelund